$KITE Kite Pharma, Inc. Insider Trading Week 42/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. in week 42/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 142,598 | |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 64.08 | 878 | 56,262 | 2,941 | 3.8 K to 2.9 K (-22.99 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 63.32 | 2,475 | 156,717 | 3,819 | 6.3 K to 3.8 K (-39.32 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 62.41 | 4,377 | 273,169 | 6,294 | 10.7 K to 6.3 K (-41.02 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 61.54 | 1,442 | 88,741 | 10,671 | 12.1 K to 10.7 K (-11.90 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 60.36 | 395 | 23,842 | 12,113 | 12.5 K to 12.1 K (-3.16 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 12,508 | 2.9 K to 12.5 K (+325.30 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | M | 6.89 | 9,000 | 62,010 | 121,000 | |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 64.19 | 465 | 29,848 | 6,342 | 6.8 K to 6.3 K (-6.83 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 63.50 | 2,007 | 127,445 | 6,807 | 8.8 K to 6.8 K (-22.77 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 62.54 | 4,702 | 294,063 | 8,814 | 13.5 K to 8.8 K (-34.79 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 61.61 | 1,375 | 84,714 | 13,516 | 14.9 K to 13.5 K (-9.23 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 60.42 | 451 | 27,249 | 14,891 | 15.3 K to 14.9 K (-2.94 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Buy | M | 6.89 | 9,000 | 62,010 | 15,342 | 6.3 K to 15.3 K (+141.91 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 34,523 | |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 107,625 | |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.25 | 84 | 5,397 | 2,198 | 2.3 K to 2.2 K (-3.68 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 63.60 | 1,600 | 101,760 | 2,282 | 3.9 K to 2.3 K (-41.22 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 62.62 | 2,800 | 175,336 | 3,882 | 6.7 K to 3.9 K (-41.90 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 61.79 | 1,300 | 80,327 | 6,682 | 8 K to 6.7 K (-16.29 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 60.08 | 361 | 21,689 | 7,982 | 8.3 K to 8 K (-4.33 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 8,343 | 7.7 K to 8.3 K (+8.38 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 7,698 | 2.2 K to 7.7 K (+250.23 %) |